Could cause temporary or reversible harm; serious harm is unlikely.
Failed Dissolution Specifications
| Brand name | LANSOPRAZOLE |
| Generic name | LANSOPRAZOLE |
| Active ingredient(s) | LANSOPRAZOLE |
| Distributed by / for | Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534 |
| NDC | 68382-771-77 |
| Full product label | Lansoprazole Delayed-Release Orally Disintegrating Tablets 15 mg, 100 Tablets (10x10 unit dose) blister pack, Rx only, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534 NDC 68382-771-77 |
| Recalling firm | Zydus Pharmaceuticals (USA) Inc |
| Distribution | Nationwide |
| Quantity | 15,144 cartons |
| Recall initiated | 2020-12-03 |
| Report date | 2020-12-23 |
| Recall completed | 2022-12-20 |
| Recall number | D-0145-2021 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Pennington NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗